|
Match
|
Document |
Document Title |
|
|
US20110293723 |
SYNTHETIC NANOCARRIER COMBINATION VACCINES
Disclosed are dosage forms and related methods, that include a first population of synthetic nanocarriers that have one or more first antigens coupled to them, one or more second antigens that are... |
|
|
US20140271720 |
Method of Treating Fungal Infection
A vaccine comprising Calnexin fragment and a method of using the vaccine to immunize a patient against fungi are disclosed. The Calnexin fragment may be either a full-length native version or a... |
|
|
US20110293701 |
MULTIVALENT SYNTHETIC NANOCARRIER VACCINES
The invention relates, at least in part, to compositions comprising populations of synthetic nanocarriers that comprise different sets of antigens as well as related methods. |
|
|
US20110293659 |
METHOD FOR THE ORAL/MUCOSAL VACCINATION BY MEANS OF RECOMBINANT YEASTS
Recombinant yeast cells are produced which are used for vaccination, among other uses for the oral vaccination by feeding. |
|
|
US20110110979 |
METHOD AND VACCINE FOR OPTIMIZING THE SPECIFIC IMMUNE RESPONSES
The present invention relates to a method for treating an infection or disease or lesion, in particular an HPV infection. Furthermore, it relates to a vaccine for treating a Human Papillomavirus... |
|
|
US20150024006 |
Allogeneic cellular immunotherapy for opportunistic infection
A method for stimulating the immune system in immunocompromised patients in order to treat opportunistic infection. The method involves the infusion of intentionally mismatched allogeneic cells.... |
|
|
US20120141526 |
Nanoemulsion vaccines
The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods and compositions for the use of nanoemulsion... |
|
|
US20140161837 |
VACCINE ADJUVANT, VACCINE COMPOSITION AND METHOD FOR PREPARING A VACCINE ADJUVANT
The disclosure provides a vaccine adjuvant, including a polysaccharide derived from Antrodia camphorata (also named Antrodia cinnamomea or Taiwanofungus camphoratus) fruiting body, wherein the... |
|
|
US20130344110 |
Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast-Based Vaccines
Embodiments of the present invention illustrate methods of treating and preventing infection due to a pathogen such as a fungal pathogen. In particular, the present invention relates to... |
|
|
US20120003277 |
NANOEMULSION VACCINES
The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides nanoemulsion compositions harboring one or more... |
|
|
US20130309269 |
Methods for Producing Yeast-Based Vaccines
The invention provides methods for culturing yeast at a neutral pH level. Yeast cultured under neutral pH conditions exhibit desirable characteristics useful for biological purposes, such as the... |
|
|
US20130039958 |
METHOD OF VACCINATION
The present invention relates to improved methods for vaccination of a subject. Particularly, the present invention discloses the use of skin antigen application to amplify and improve a... |
|
|
US20110150940 |
DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION
This invention provides a dry powder composition for poultry vaccination via inhalation comprising an effective amount of a poultry vaccine agent, and a supporting amount of carriers for said... |
|
|
US20120014995 |
PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST DISSEMINATED CANDIDIASIS AND OTHER INFECTIOUS AGENTS
The invention provides a vaccine including an isolated Als protein family member having cell adhesion activity, or an immunogenic fragment thereof, with an adjuvant in a pharmaceutically... |
|
|
US20110150924 |
Device, Method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
A method for enhancing an immune response in a vertebrate subject is described. The method includes providing at least one energy stimulus configured to modulate one or more nervous system... |
|
|
US20110206729 |
MUCOSAL VACCINE USING CATIONIC NANOGEL
A mucosal vaccine for the prevention or treatment of microbial infections is described that is capable of inducing vaccine antigen-specific immune responses in an organism without the addition of... |
|
|
US20150250872 |
VACCINE COMPOSITIONS AND METHODS OF USE
The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid. The disclosure also provides methods of... |
|
|
US20140065189 |
ADJUVANT COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES TO POLYNUCLEOTIDE-BASED VACCINES
The invention provides adjuvants, immunogenic compositions, and methods useful for polynucleotide-based vaccination and immune response. In particular, the invention provides an adjuvant of... |
|
|
US20110165197 |
ADJUVANT COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES TO POLYNUCLEOTIDE-BASED VACCINES
The invention provides adjuvants, immunogenic compositions, and methods useful for polynucleotide-based vaccination and immune response. In particular, the invention provides an adjuvant of... |
|
|
US20110206755 |
METHODS AND PRODUCTS FOR MANIPULATING UNCOUPLING PROTEIN EXPRESSION
The invention is based in part on the discovery that uncoupling proteins (UCPs) are expressed in the plasma membrane of rapidly dividing cells but not of growth arrested, chemotherapy resistant... |
|
|
US20120263753 |
BENZONAPHTHYRIDINE-CONTAINING VACCINES
The invention provides, inter alia, immunogenic compositions that comprise (a) a first antigen, (b) polymeric particles and (c) a benzonaphthyridine compound, which compositions elicits an immune... |
|
|
US20140037689 |
PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST DISSEMINATED CANDIDIASIS AND OTHER INFECTIOUS AGENTS
The invention provides a vaccine including an isolated Als protein family member having cell adhesion activity, or an immunogenic fragment thereof, with an adjuvant in a pharmaceutically... |
|
|
US20110243972 |
PROSTATE STEM CELL ANTIGEN VACCINES AND USES THEREOF
This invention relates to the identification of prostate stem cell antigen (PSCA) as a target of clinically relevant antitumor immune responses. The invention provides vaccines comprising PSCA, or... |
|
|
US20110243979 |
Method of Transcutaneous Immunization Using Antigen
Transcutaneous immunization can deliver antigen to the immune system through the stratum corneum without physical or chemical penetration to the dermis layer of the skin. This delivery system... |
|
|
US20130344111 |
Mass-Spectral Method for Selection, and De-Selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
A method and system for predicting in advance of treatment whether a cancer patient is likely, or not likely, to obtain benefit from administration of a yeast-based immune response generating... |
|
|
US20110129494 |
Vaccine Formulations Comprising Saponin-containing Adjuvants
The present invention provides for a novel oil-in-water (O/W) emulsion, with increased stability in the presence of bacterial or viral suspensions, especially those concentrated and non-purified... |
|
|
US20110052638 |
ALLERGENS FROM ASPERGILLUS VERSICOLOR, AND METHOD OF DETECTING A MOLD ALLERGY CAUSED BY INTERIOR ROOMS
The invention relates to seven allergens of Aspergillus versicolor which are suitable for specific diagnostics of this mold which predominantly pollutes the interior. The invention is also... |
|
|
US20120201845 |
TRANSCUTANEOUS IMMUNIZATION WITHOUT HETEROLOGOUS ADJUVANT
Transcutaneous immunization can deliver antigen to the immune system through the stratum corneum without physical or chemical penetration to the dermis layer of the skin. This delivery system... |
|
|
US20150157699 |
METHODS OF TREATING PSORIASIS USING CANDIDA ANTIGEN
A method for using a candida antigen in the treatment of psoriasis. In an embodiment, the method comprises periodically administering, to a patient having psoriasis, a candida antigen until... |
|
|
US20120156287 |
Use of Vitelline Protein B as a Microencapsulating Additive
The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide... |
|
|
US20100297165 |
IMMUNOSTIMULATORY COMBINATIONS OF TLR LIGANDS AND METHODS OF USE
The present invention provides immunostimulatory combinations of TLR ligands and therapeutic and/or prophylactic methods that include administering an immunostimulatory combination to a subject.... |
|
|
US20130295147 |
GAS-FILLED MICROVESICLES FOR USE AS VACCINE
Gas-filled microvesicles comprising an antigen bound thereto and to aqueous suspensions containing said microvesicles, for use in immunomodulating formulations, in particular as a vaccine. The... |
|
|
US20130149340 |
Yeast-Based Vaccines As Immunotherapy
Compositions and methods for treating and/or preventing a variety of diseases and conditions that are amenable to immunotherapy and, in one particular embodiment, compositions and methods for... |
|
|
US20110159042 |
PYTHIUM IMMUNOTHERAPY
A method and vaccine for modulating the immune system of animals with diseases other than caused by P. insidiosum, comprising administering to the animal immune modulating effective amount of the... |
|
|
US20120244182 |
USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION
The invention provides immunostimulatory compositions and methods of administration thereof. Also provided are methods of administering a tryptanthrin compound in an effective amount to enhance... |
|
|
US20130330374 |
TREATMENT OF IMMUNE DISEASE BY MUCOSAL DELIVERY OF ANTIGENS USING GENETICALLY MODIFIED LACTOBACILLUS
The present invention relates to the treatment of autoimmune and allergic diseases by mucosal delivery by micro-organism, in particular Lactococcus lactis, of secreted immunodominant antigens. |
|
|
US20110135684 |
Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro
A method for treating and/or preventing certain ailments by administering to a person in need thereof L-α-lysophosphatidylcholine as an agent for activating the immune system of the person. Also,... |
|
|
US20140220078 |
Method for Preparing Glucans Based on Aspergillus niger
This application concerns a method for preparing glucan from Aspergillus niger, characterised in that it comprises (i) the at least partial deacetylation of the mycelium of A. niger; (ii) acid... |
|
|
US20110045026 |
PRODUCTION OF FUNGAL EXTRACELLULAR IMMUNE STIMULATING COMPOUNDS
A process is described for the production of an immunostimulant by submerged cultivation of Lentinus edodes in which mycelium from agar plates or a fermentation broth is added to a liquid medium... |
|
|
US20110171267 |
ANTI-FUNGAL COMPOSITION
A multivalent fungal vaccine comprising one or more heat-inactivated fungal antigens, wherein at least one fungal antigen is effective in producing an immune response in a host when said vaccine... |
|
|
US20110262457 |
MODULATION OF THE IMMUNE RESPONSE
Methods for increasing the generation of IL-17-producing T cells (TH17) in vivo and in vitro, and enriched populations of TH17 cells for the treatment of diseases benefiting from an induced or... |
|
|
US20140017313 |
FORMULATIONS
This invention relates to compositions for delivering one or more active ingredients, and more particularly to compositions, e.g. beads, comprising a matrix material which matrix material... |
|
|
US20150147355 |
Compositions and Methods of Vaccination
The present invention relates to a vaccination strategy that establishes protective immunity, including a protective memory T-cell population. |
|
|
US20110206728 |
DNA VACCINES, USES FOR UNPROCESSED ROLLING CIRCLE AMPLIFICATION PRODUCT AND METHODS FOR MAKING THE SAME
A method of eliciting an immune response in an organism comprising: providing an unprocessed rolling circle amplification (RCA) product; and administering an effective amount of the unprocessed... |
|
|
US20120258135 |
IMMUNOGENIC ANTI-INFLAMMATORY COMPOSITIONS
The invention provides methods of formulating an anti-inflammatory composition for treating inflammatory conditions in a specific organ or tissue. The method involves selecting at least one... |
|
|
US20120244181 |
CREATING BIOENGINEERED LYMPH NODES
The invention provides compositions and methods of treating various conditions, including tumors, with compositions comprising dendritic cells expressing exogenous chemokines. |
|
|
US20130189351 |
LIPIDS SUITABLE FOR LIPOSOMAL DELIVERY OF PROTEIN CODING RNA
RNA is encapsulated within a liposome for in vivo delivery. The RNA encodes a polypeptide of interest, such as an immunogen for immunisation purposes. The liposome includes at least one compound... |
|
|
US20120328655 |
IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR INDUCING HUMORAL AND CELLULAR IMMUNE RESPONSES
Compositions and methods are provided herein for improved dual immunization strategies that induce in a subject an immune response that includes a humoral immune response and cellular immune... |
|
|
US20110111017 |
USE OF IMMUNOGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOGEN INFECTIONS
The invention provides compositions featuring cationic liposome nucleic acid molecules complexed with pathogen derived antigen and methods of using such compositions for the treatment or... |
|
|
US20110177120 |
MYCOBACTERIUM TUBERCULOSIS VACCINE
The present invention relates to the use of live mycobacterium of the M. tuberculosis complex for preparing a medicament, wherein the function of the zmp1-gene is inactivated, pharmaceutical... |